EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Effectiveness and Safety of Rituximab Compared to Cyclophosphamide in ANCA-Associated Vasculitis: A Systematic Review

Qudsia Ahmad, Abdul Rehman Arshad, Muhammad Iqbal

Annals of King Edward Medical University · 30.06.2026 · 32 (2)

DOI: 10.21649/akemu.v32i2.6176 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of King Edward Medical University, online erschienen am 30.06.2026. Verfasst von Qudsia Ahmad und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a potentially life-threatening systemic disease characterized by necrotizing inflammation of small- to medium-sized blood vessels leading to endothelial injury and widespread organ damage. This systematic review was done to compare the efficacy and safety of rituximab with cyclophosphamide in AAV. For this PROSPERO registered review, the literature was searched across PubMed, Cochrane Library, LILACS, and CNKI databases, focusing on randomized trials and quasi-experimental studies. Adolescents/ adult patients with antineutrophil cytoplasmic antibody-associated vasculitis, having positive ANCA assays. Of the 919 records identified, only one study and five additional reports were included. Among 197 patients, rituximab was non-inferior to cyclophosphamide in inducing remission at 6 months, superior in inducing remission after relapses, and non-inferior in maintaining complete remission at 18 months, with similar relapse rates. Rituximab has an efficacy comparable to cyclophosphamide for the initial treatment of antineutrophil cytoplasmic antibody-associated vasculitis.

Zitieren

APA

Ahmad, Q., Arshad, A. R., & Iqbal, M. (2026). Effectiveness and Safety of Rituximab Compared to Cyclophosphamide in ANCA-Associated Vasculitis: A Systematic Review. Annals of King Edward Medical University, 32(2). https://doi.org/10.21649/akemu.v32i2.6176

Vancouver

Ahmad Q, Arshad AR, Iqbal M. Effectiveness and Safety of Rituximab Compared to Cyclophosphamide in ANCA-Associated Vasculitis: A Systematic Review. Annals of King Edward Medical University. 2026;32(2). doi:10.21649/akemu.v32i2.6176

BibTeX
@article{Ahmad2026,
  author = {Ahmad, Qudsia and Arshad, Abdul Rehman and Iqbal, Muhammad},
  title = {Effectiveness and Safety of Rituximab Compared to Cyclophosphamide in ANCA-Associated Vasculitis: A Systematic Review},
  journal = {Annals of King Edward Medical University},
  year = {2026},
  volume = {32},
  number = {2},
  doi = {10.21649/akemu.v32i2.6176}
}
Kostenlos starten →